Safety of intranasal corticosteroids in acute rhinosinusitis

Treatment guidelines for acute rhinosinusitis (RS) recommend the use of intranasal corticosteroids (INSs) as monotherapy or adjunctive therapy. However, the adverse event (AE) profiles of oral glucocorticoids, which result largely from the systemic absorption of those agents, have engendered concern...

Descripción completa

Detalles Bibliográficos
Autor principal: Demoly, Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2008
Materias:
Current Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115254/
https://www.ncbi.nlm.nih.gov/pubmed/19144302
http://dx.doi.org/10.1016/j.amjoto.2007.11.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115254/
https://www.ncbi.nlm.nih.gov/pubmed/19144302
http://dx.doi.org/10.1016/j.amjoto.2007.11.004

Ejemplares similares